Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 May;65(5):1761–1766. doi: 10.1128/iai.65.5.1761-1766.1997

Effects of gamma interferon and nitric oxide on the interaction of Mycobacterium avium subsp. paratuberculosis with bovine monocytes.

B Zhao 1, M T Collins 1, C J Czuprynski 1
PMCID: PMC175213  PMID: 9125559

Abstract

In this study, we examined the effects of recombinant bovine gamma interferon (rIFN-gamma) and nitric oxide (NO) on the interaction of M. avium subsp. paratuberculosis with bovine monocytes. Monocytes pretreated with rIFN-gamma exhibited slightly increased phagocytosis of M. avium subsp. paratuberculosis and modest inhibition of the intracellular growth of this microorganism. The number of viable intracellular bacilli decreased earlier in rIFN-gamma-pretreated monocytes than in control monocytes. After infection with M. avium subsp. paratuberculosis, NO was not constitutively released, but NO release from infected monocytes was induced by treatment with rIFN-gamma or with rIFN-gamma and lipopolysaccharide (LPS). Release of nitric oxide was inhibited by addition of N(G)-monomethyl-L-arginine; however, inhibition of nitric oxide did not alter the pattern of intracellular survival of M. avium subsp. paratuberculosis in rIFN-gamma-treated bovine monocytes. Although chemically generated nitric oxide killed M. avium subsp. paratuberculosis in a cell-free system in vitro, the amount of nitric oxide required was far greater than that released from infected monocytes stimulated with rIFN-gamma and LPS. Our data suggest that rIFN-gamma activates M. avium subsp. paratuberculosis-infected bovine monocytes to release nitric oxide but only modestly increases antimycobacterial activity of monocytes against this organism. This may be due, in part, to the fact that the amount of nitric oxide produced by rIFN-gamma-activated bovine monocytes is insufficient to kill intracellular M. avium subsp. paratuberculosis bacilli in vitro.

Full Text

The Full Text of this article is available as a PDF (192.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams L. B., Franzblau S. G., Vavrin Z., Hibbs J. B., Jr, Krahenbuhl J. L. L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol. 1991 Sep 1;147(5):1642–1646. [PubMed] [Google Scholar]
  2. Adler H., Frech B., Thöny M., Pfister H., Peterhans E., Jungi T. W. Inducible nitric oxide synthase in cattle. Differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J Immunol. 1995 May 1;154(9):4710–4718. [PubMed] [Google Scholar]
  3. Albina J. E. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol. 1995 Dec;58(6):643–649. doi: 10.1002/jlb.58.6.643. [DOI] [PubMed] [Google Scholar]
  4. Appelberg R., Orme I. M. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology. 1993 Nov;80(3):352–359. [PMC free article] [PubMed] [Google Scholar]
  5. Britton W. J., Roche P. W., Winter N. Mechanisms of persistence of mycobacteria. Trends Microbiol. 1994 Aug;2(8):284–288. doi: 10.1016/0966-842x(94)90005-1. [DOI] [PubMed] [Google Scholar]
  6. Chan J., Tanaka K., Carroll D., Flynn J., Bloom B. R. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun. 1995 Feb;63(2):736–740. doi: 10.1128/iai.63.2.736-740.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chan J., Xing Y., Magliozzo R. S., Bloom B. R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992 Apr 1;175(4):1111–1122. doi: 10.1084/jem.175.4.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chiodini R. J., Van Kruiningen H. J., Merkal R. S. Ruminant paratuberculosis (Johne's disease): the current status and future prospects. Cornell Vet. 1984 Jul;74(3):218–262. [PubMed] [Google Scholar]
  9. Chiodini R. J., Van Kruiningen H. J., Thayer W. R., Coutu J. A. Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J Clin Microbiol. 1986 Sep;24(3):357–363. doi: 10.1128/jcm.24.3.357-363.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cooper A. M., Dalton D. K., Stewart T. A., Griffin J. P., Russell D. G., Orme I. M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993 Dec 1;178(6):2243–2247. doi: 10.1084/jem.178.6.2243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cunha F. Q., Weiser W. Y., David J. R., Moss D. W., Moncada S., Liew F. Y. Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. J Immunol. 1993 Mar 1;150(5):1908–1912. [PubMed] [Google Scholar]
  12. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993 Mar 19;259(5102):1739–1742. doi: 10.1126/science.8456300. [DOI] [PubMed] [Google Scholar]
  13. Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol. 1994 May;55(5):682–684. doi: 10.1002/jlb.55.5.682. [DOI] [PubMed] [Google Scholar]
  14. Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol. 1991 Jan;132(1):150–157. doi: 10.1016/0008-8749(91)90014-3. [DOI] [PubMed] [Google Scholar]
  15. Douvas G. S., Looker D. L., Vatter A. E., Crowle A. J. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun. 1985 Oct;50(1):1–8. doi: 10.1128/iai.50.1.1-8.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fifis T., Corner L. A., Rothel J. S., Wood P. R. Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens. Scand J Immunol. 1994 Mar;39(3):267–274. doi: 10.1111/j.1365-3083.1994.tb03370.x. [DOI] [PubMed] [Google Scholar]
  17. Flesch I. E., Kaufmann S. H. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun. 1991 Sep;59(9):3213–3218. doi: 10.1128/iai.59.9.3213-3218.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Flesch I., Kaufmann S. H. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol. 1987 Jun 15;138(12):4408–4413. [PubMed] [Google Scholar]
  19. Flynn J. L., Chan J., Triebold K. J., Dalton D. K., Stewart T. A., Bloom B. R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993 Dec 1;178(6):2249–2254. doi: 10.1084/jem.178.6.2249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982 Oct;126(1):131–138. doi: 10.1016/0003-2697(82)90118-x. [DOI] [PubMed] [Google Scholar]
  21. Hanano R., Kaufmann S. H. Nitric oxide production and mycobacterial growth inhibition by murine alveolar macrophages: the sequence of rIFN-gamma stimulation and Mycobacterium bovis BCG infection determines macrophage activation. Immunol Lett. 1995 Feb;45(1-2):23–27. doi: 10.1016/0165-2478(94)00193-u. [DOI] [PubMed] [Google Scholar]
  22. Holland S. M., Eisenstein E. M., Kuhns D. B., Turner M. L., Fleisher T. A., Strober W., Gallin J. I. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med. 1994 May 12;330(19):1348–1355. doi: 10.1056/NEJM199405123301904. [DOI] [PubMed] [Google Scholar]
  23. Kamijo R., Le J., Shapiro D., Havell E. A., Huang S., Aguet M., Bosland M., Vilcek J. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med. 1993 Oct 1;178(4):1435–1440. doi: 10.1084/jem.178.4.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kamijo R., Shapiro D., Le J., Huang S., Aguet M., Vilcek J. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6626–6630. doi: 10.1073/pnas.90.14.6626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kaplan G. Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiology. 1994 Oct;191(4-5):564–568. doi: 10.1016/S0171-2985(11)80463-8. [DOI] [PubMed] [Google Scholar]
  26. Kaplan S. S., Lancaster J. R., Jr, Basford R. E., Simmons R. L. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun. 1996 Jan;64(1):69–76. doi: 10.1128/iai.64.1.69-76.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kaufmann S. H. Immunity to intracellular bacteria. Annu Rev Immunol. 1993;11:129–163. doi: 10.1146/annurev.iy.11.040193.001021. [DOI] [PubMed] [Google Scholar]
  28. Lambrecht R. S., Carriere J. F., Collins M. T. A model for analyzing growth kinetics of a slowly growing Mycobacterium sp. Appl Environ Microbiol. 1988 Apr;54(4):910–916. doi: 10.1128/aem.54.4.910-916.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lisby G., Andersen J., Engbaek K., Binder V. Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. Scand J Gastroenterol. 1994 Oct;29(10):923–929. doi: 10.3109/00365529409094864. [DOI] [PubMed] [Google Scholar]
  30. Marletta M. A. Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci. 1989 Dec;14(12):488–492. doi: 10.1016/0968-0004(89)90181-3. [DOI] [PubMed] [Google Scholar]
  31. McDonough K. A., Kress Y., Bloom B. R. The interaction of Mycobacterium tuberculosis with macrophages: a study of phagolysosome fusion. Infect Agents Dis. 1993 Aug;2(4):232–235. [PubMed] [Google Scholar]
  32. Mishina D., Katsel P., Brown S. T., Gilberts E. C., Greenstein R. J. On the etiology of Crohn disease. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9816–9820. doi: 10.1073/pnas.93.18.9816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nakagawara A., Nathan C. F. A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells. J Immunol Methods. 1983 Jan 28;56(2):261–268. doi: 10.1016/0022-1759(83)90418-0. [DOI] [PubMed] [Google Scholar]
  34. Reiner N. E. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today. 1994 Aug;15(8):374–381. doi: 10.1016/0167-5699(94)90176-7. [DOI] [PubMed] [Google Scholar]
  35. Riley L. W. Determinants of cell entry and intracellular survival of Mycobacterium tuberculosis. Trends Microbiol. 1995 Jan;3(1):27–31. doi: 10.1016/s0966-842x(00)88865-4. [DOI] [PubMed] [Google Scholar]
  36. Rook G. A., Steele J., Ainsworth M., Champion B. R. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology. 1986 Nov;59(3):333–338. [PMC free article] [PubMed] [Google Scholar]
  37. Stuehr D. J., Griffith O. W. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol. 1992;65:287–346. doi: 10.1002/9780470123119.ch8. [DOI] [PubMed] [Google Scholar]
  38. Thompson D. E. The role of mycobacteria in Crohn's disease. J Med Microbiol. 1994 Aug;41(2):74–94. doi: 10.1099/00222615-41-2-74. [DOI] [PubMed] [Google Scholar]
  39. Toba H., Crawford J. T., Ellner J. J. Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon. Infect Immun. 1989 Jan;57(1):239–244. doi: 10.1128/iai.57.1.239-244.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yoo H. S., Rutherford M. S., Maheswaran S. K., Srinand S., Ames T. R. Induction of nitric oxide production by bovine alveolar macrophages in response to Pasteurella haemolytica A1. Microb Pathog. 1996 Jun;20(6):361–375. doi: 10.1006/mpat.1996.0034. [DOI] [PubMed] [Google Scholar]
  41. Zhao B. Y., Collins M. T., Czuprynski C. J. Induction of L-arginine-dependent production of nitric oxide in bovine monocytes by interferon gamma and lipopolysaccharide. Res Vet Sci. 1996 Mar;60(2):190–192. doi: 10.1016/s0034-5288(96)90019-3. [DOI] [PubMed] [Google Scholar]
  42. Zurbrick B. G., Czuprynski C. J. Ingestion and intracellular growth of Mycobacterium paratuberculosis within bovine blood monocytes and monocyte-derived macrophages. Infect Immun. 1987 Jul;55(7):1588–1593. doi: 10.1128/iai.55.7.1588-1593.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zurbrick B. G., Follett D. M., Czuprynski C. J. Cytokine regulation of the intracellular growth of Mycobacterium paratuberculosis in bovine monocytes. Infect Immun. 1988 Jul;56(7):1692–1697. doi: 10.1128/iai.56.7.1692-1697.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES